Surgical Oncology / Cytoreductive Surgery & HIPEC

Cytoreductive surgery & HIPEC. Specialist care for selected cases.

A treatment approach considered for certain cancers that have spread to the lining of the abdominal cavity. Suitability depends on the cancer type, extent of disease, overall health and findings from a detailed specialist assessment.

Request a Consultation
01 — SURGICAL ONCOLOGY

Careful evaluation.
Individualised planning.

Surgical team in an operating theatre; illustrative medical image
CYTOREDUCTIVE SURGERY & HIPEC
The Service

Understanding CRS and HIPEC.

Cytoreductive surgery (CRS) aims to remove visible tumour deposits from the abdominal cavity. In selected cases, it may be combined with hyperthermic intraperitoneal chemotherapy (HIPEC), in which warmed chemotherapy is circulated within the abdomen during surgery. The approach is not suitable for every patient or every cancer.

Dr. Harish Kumar H’s curriculum vitae lists cytoreductive surgery and HIPEC among his surgical skills. Assessment usually requires review of the diagnosis, scans, previous treatments, distribution of disease and general fitness. A specialist team can then discuss whether this approach or another treatment pathway is appropriate for the individual case.

Conditions Assessed

Peritoneal disease and selected cancers.

CRS and HIPEC may be considered for specific cancers involving the peritoneum after careful staging and multidisciplinary review. The likely benefits, risks and alternatives vary with each diagnosis and the extent of disease.

01 / COLORECTAL

Colorectal Cancer with Peritoneal Spread

Assessment of selected cases where bowel cancer has spread to the lining of the abdomen.

02 / APPENDICEAL

Appendiceal Tumours

Review of selected appendiceal cancers and related conditions involving the peritoneal surface.

03 / PSEUDOMYXOMA

Pseudomyxoma Peritonei

Evaluation of this uncommon condition, which can involve mucin-producing tumours within the abdomen.

04 / PERITONEAL

Primary Peritoneal Malignancies

Specialist review of selected cancers that originate in or affect the peritoneal lining.

05 / GASTRIC

Selected Gastric Cancers

Assessment of the diagnosis and disease extent to determine whether a specialised treatment approach may be discussed.

06 / COMPLEX CASES

Other Peritoneal Surface Tumours

Individual review of other tumour types affecting the abdominal lining, based on specialist evidence and suitability.

Treatment Approach

A considered plan for every patient.

CRS and HIPEC are complex treatments that require careful selection and coordinated planning. The treatment team weighs the possible benefits against surgical risks, recovery needs and other available options before making a recommendation.

01 / ASSESSMENT

Staging and Suitability Review

Imaging, pathology, previous treatment details and general fitness are reviewed to understand the extent of disease and whether surgery should be considered.

02 / SURGERY

Cytoreductive Surgery

When appropriate, surgery aims to remove visible tumour deposits. The scope of the operation depends on where the disease is located and what can be safely removed.

03 / HIPEC

Heated Intraperitoneal Chemotherapy

HIPEC may be administered during the same operation for selected patients. The decision, drug protocol and overall treatment plan depend on the diagnosis and specialist-team recommendation.